Explore
Trendline
CervoMed Inc. Reports Zero Revenue and Increased Net Loss in Q1 2026
CervoMed Inc. Reports Zero Revenue and Increased Net Loss in Q1 2026
Read More
Trendline
Longeveron Reports Q1 Financial Results and Strategic Updates
Longeveron Reports Q1 Financial Results and Strategic Updates
Read More
Trendline
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Read More
Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Read More
Trendline
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Read More
Trendline
INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107
INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107
Read More
Trendline
Cabaletta Bio Reports Increased Net Loss in Q1 2026 Amid Ongoing Clinical Developments
Cabaletta Bio Reports Increased Net Loss in Q1 2026 Amid Ongoing Clinical Developments
Read More
Trendline
REGENXBIO Faces Setbacks with Duchenne Gene Therapy Amid Safety Concerns
REGENXBIO Faces Setbacks with Duchenne Gene Therapy Amid Safety Concerns
Read More
Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Read More
Trendline
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Read More
Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Read More
